Resources & Support

As a science-driven and patient-focused company, Incyte aims to make a difference—for patients, medical professionals, organizations, the broader healthcare community and all of our global stakeholders.

For Patients

Voices of MPN Logo

Patient Support

Voices of MPN is an education and awareness website that links people affected by myeloproliferative neoplasms (MPNs) to disease information, educational programs, helpful resources and tips and community activities. This initiative also invites patients and caregivers to share their stories and spread awareness about these rare, chronic blood cancers.

Learn more about VoicesofMPN


TestMyCholangio is a website designed to educate patients with cholangiocarcinoma about molecular profiling and the role it may play in informing management decisions. Here, patients can find information and resources to help encourage productive discussions with their healthcare professionals.

Learn more about TestMyCholangio

Image of IncyteCares logo a program that offers access, reimbursement, education and support.

Patient Assistance

Through IncyteCARES, we strive to implement initiatives to support patients and remove any possible barriers to access to our medicines.

IncyteCARES, our industry-leading access and patient assistance program, provides financial assistance to eligible patients for some costs associated with their Jakafi or Pemazyre prescription. This comprehensive program also offers patients ongoing education and resources as well as a dedicated nursing support program.

Learn more about IncyteCARES

Through My Mission Support, Incyte and MorphoSys are committed to supporting patients throughout their treatment journeys and are working together to help lower patient access barriers.

As part of this commitment, the Companies have launched My Mission Support, a robust patient support program offering financial assistance, ongoing education and other resources to eligible patients who are prescribed Monjuvi in the United States.

Learn more about My Mission Support

For Healthcare Professionals

Image of MPN CONNECT Logo

A Library of MPN Resources

MPN Connect is a website that offers a variety of professional resources about myeloproliferative neoplasms (MPNs)—including myelofibrosis, polycythemia vera and essential thrombocythemia. These include informative articles, diagnostic tools, videos and podcasts from industry leaders and more.

Learn more about MPN Connect


Advancing the understanding of FGFR2 fusions

FGFRScience is a website developed to help inform healthcare professionals about the role of FGFR2 fusions in intrahepatic cholangiocarcinoma, and how proactively identifying these clinically significant genomic alteration through next generation sequencing may help inform how each patient's disease is managed.

Learn more about FGFRScience

CCA Logo

Cholangiocarcinoma Europe Website

The Cholangiocarcinoma Europe website helps European healthcare professionals learn more about cholangiocarcinoma (CCA). Cholangiocarcinomas (CCAs) are diverse biliary epithelial tumours involving the intrahepatic, perihilar and distal parts of the biliary tree. Each anatomical subtype has distinct epidemiology, molecular characteristics, prognosis and strategy for clinical management.

Learn more about Cholangiocarcinoma

Image of medical information logo call us at 1-855-4med-info (855-463-3463).

Medical Information

Incyte is committed to providing timely and accurate product information to healthcare professionals upon request.

In the United States

If you are seeking medical information on our products, or wish to meet with a Medical Science Liaison, please visit To report a possible Adverse Event or Product Complaint related to an Incyte product, contact Incyte Medical Information by calling 1-855-4-MEDINFO (1-855-463-3463).

Outside of the United States

If you need medical information or have a medical question, please visit To report a possible Adverse Event or Product Complaint related to an Incyte product, contact Incyte Global Medical Information.